Impedimed - L-Dex® Analysis for Lymphedema

Features of this product

• The L-Dex score, only available from ImpediMed, is designed to detect small lymphedema-related fluid changes in the limbs.
• L-Dex compares the fluid in a limb at-risk for lymphedema to a healthy limb in order to help detect lymphedema.
• FDA-cleared for unilateral and bilateral secondary lymphedema of the arms and legs, in women and men.
• L-Dex is validated to detect lymphedema at its earliest, subclinical stage
• Detects fluid changes as small as 36 ml (2.4 tablespoons)1
• Validated against lymphoscintigraphy2
• 80% Sensitive and 90% Specific in detecting subclinical lymphedema following cancer surgery with a 6.5 change from a pre-treatment baseline3
• 81% lower incidence of chronic cancer-related lymphedema with BIS L-Dex monitoring and intervention than with circumference monitoring in a meta-analysis of 67,000 patients4
• Statistically lower rates of chronic lymphedema in high-risk patients and short-term and long-term follow-up4 Consistent reduction in lymphedema progression, study after study

To contact ImpediMed Limited about Impedimed L-Dex® Analysis for Lymphedema use Get a quote.

Features of this product

• The L-Dex score, only available from ImpediMed, is designed to detect small lymphedema-related fluid changes in the limbs.
• L-Dex compares the fluid in a limb at-risk for lymphedema to a healthy limb in order to help detect lymphedema.
• FDA-cleared for unilateral and bilateral secondary lymphedema of the arms and legs, in women and men.
• L-Dex is validated to detect lymphedema at its earliest, subclinical stage
• Detects fluid changes as small as 36 ml (2.4 tablespoons)1
• Validated against lymphoscintigraphy2
• 80% Sensitive and 90% Specific in detecting subclinical lymphedema following cancer surgery with a 6.5 change from a pre-treatment baseline3
• 81% lower incidence of chronic cancer-related lymphedema with BIS L-Dex monitoring and intervention than with circumference monitoring in a meta-analysis of 67,000 patients4
• Statistically lower rates of chronic lymphedema in high-risk patients and short-term and long-term follow-up4 Consistent reduction in lymphedema progression, study after study

Read less...

To contact ImpediMed Limited about Impedimed L-Dex® Analysis for Lymphedema use Get a quote.